STAT+: Former Immunomedics executives are charged with insider trading

Two former executives at Immuomedics were charged with insider trading by U.S. authorities in connection with information about late-stage clinical trial results of a promising cancer drug, which later prompted Gilead Sciences (GILD) to buy the company.

Usama Malik, who had been chief financial officer, and Lauren Wood, the former chief communications officer, were arrested for purchasing Immunomedic stock shortly before positive trial results were released publicly in April 2020. At the time, the pair was romantically involved and lived together in Washington, D.C., according to a criminal complaint filed in federal court in New Jersey.

Continue to STAT+ to read the full story…

Read Original Article: STAT+: Former Immunomedics executives are charged with insider trading »